<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>PrimeKG Pathfinding Benchmark ‚Äì Overview</title>
  <link rel="stylesheet" href="style.css">
</head>
<body>

  <header>
  <div class="container">
    <h1>PrimeKG Pathfinding Algorithm Benchmark Laboratory</h1>
    <p class="subtitle">Benchmarking Graph Algorithms for Drug Repurposing Discovery</p>

    <nav class="main-nav" style="margin-top: 20px;">
      <a href="index.html" class="active">Overview</a>
      <a href="groundtruths.html">Ground Truths & Methods</a>
      <a href="results.html">Results</a>
    </nav>
  </div>
</header>


  <main class="container">
    <!-- Project Overview -->
    <section id="overview">
      <h2>Project Overview</h2>
      <p>
        This project investigates and benchmarks pathfinding algorithms on the 
        <strong>PrimeKG</strong> (Precision Medicine Knowledge Graph) to evaluate their 
        effectiveness in discovering mechanistically plausible drug repurposing candidates.
      </p>
      <p>
        We aim to answer a critical question: <em>Can standard graph algorithms find 
        biologically meaningful pathways, or do they fall into "shortcut traps" that 
        produce statistically short but mechanistically meaningless paths?</em>
      </p>
    </section>

    <!-- Motivation -->
    <section id="motivation">
      <h2>Motivation</h2>
      <div class="motivation-grid">
        <div class="motivation-card">
          <h3>The Hub Trap</h3>
          <p>
            High-degree nodes like TP53 or UBC act as "shortcuts" that algorithms prefer, 
            but these paths lack biological specificity and explanatory power.
          </p>
        </div>
        <div class="motivation-card">
          <h3>The Drug Trap</h3>
          <p>
            Naive algorithms often route through other drugs as intermediates, 
            producing paths like "Drug A ‚Üí Drug B ‚Üí Disease" that are pharmacologically meaningless.
          </p>
        </div>
        <div class="motivation-card">
          <h3>The Disease Trap</h3>
          <p>
            Paths may jump through unrelated diseases that share genetic risk factors, 
            creating spurious associations without mechanistic basis.
          </p>
        </div>
      </div>
    </section>

    <!-- Dataset -->
    <section id="dataset">
      <h2>The Dataset: PrimeKG</h2>
      <p>
        <a href="https://github.com/mims-harvard/PrimeKG" target="_blank">PrimeKG</a> is a 
        precision medicine knowledge graph that integrates 20+ biomedical resources.
      </p>
      <div class="stats-grid">
        <div class="stat-card">
          <span class="stat-number">8.1M+</span>
          <span class="stat-label">Edges (Relationships)</span>
        </div>
        <div class="stat-card">
          <span class="stat-number">129K+</span>
          <span class="stat-label">Nodes (Entities)</span>
        </div>
        <div class="stat-card">
          <span class="stat-number">10</span>
          <span class="stat-label">Entity Types</span>
        </div>
        <div class="stat-card">
          <span class="stat-number">18</span>
          <span class="stat-label">Relationship Types</span>
        </div>
      </div>

      <h3>Entity Types</h3>
      <div class="entity-types">
        <span class="entity-tag drug">Drug</span>
        <span class="entity-tag gene">Gene/Protein</span>
        <span class="entity-tag disease">Disease</span>
        <span class="entity-tag anatomy">Anatomy</span>
        <span class="entity-tag pathway">Pathway</span>
        <span class="entity-tag phenotype">Effect/Phenotype</span>
        <span class="entity-tag bp">Biological Process</span>
        <span class="entity-tag mf">Molecular Function</span>
        <span class="entity-tag cc">Cellular Component</span>
        <span class="entity-tag exposure">Exposure</span>
      </div>
    </section>

    <!-- Key Pathway: Tirofiban ‚Üí Acute Coronary Syndrome -->
    <section id="pathway">
      <h2>Example: Tirofiban ‚Üí Acute Coronary Syndrome</h2>
      <p>
        Below is a mechanistically grounded drug‚Äìdisease pathway showing how 
        <strong>Tirofiban</strong> treats <strong>Acute Coronary Syndrome</strong> 
        by inhibiting platelet aggregation via integrin receptors.
      </p>

      <div class="pathway-container">
        <div class="pathway-visualization">
          <!-- Node 1: Tirofiban -->
          <div class="pathway-node drug">
            <div class="node-icon">üíä</div>
            <div class="node-name">Tirofiban</div>
            <div class="node-meta">DB00775 | Drug</div>
          </div>

          <div class="pathway-edge">
            <div class="edge-line"></div>
            <div class="edge-label">targets</div>
          </div>

          <!-- Node 2: Integrin alpha-IIb -->
          <div class="pathway-node gene">
            <div class="node-icon">üß¨</div>
            <div class="node-name">Integrin Œ±IIb</div>
            <div class="node-meta">3674 | Gene/Protein</div>
          </div>

          <div class="pathway-edge">
            <div class="edge-line"></div>
            <div class="edge-label">participates in</div>
          </div>

          <!-- Node 3: Platelet aggregation -->
          <div class="pathway-node pathway">
            <div class="node-icon">üîÑ</div>
            <div class="node-name">Platelet aggregation</div>
            <div class="node-meta">70527 | Biological Process</div>
          </div>

          <div class="pathway-edge">
            <div class="edge-line"></div>
            <div class="edge-label">mediated by</div>
          </div>

          <!-- Node 4: Integrin beta-3 -->
          <div class="pathway-node gene">
            <div class="node-icon">üß¨</div>
            <div class="node-name">Integrin Œ≤3</div>
            <div class="node-meta">3690 | Gene/Protein</div>
          </div>

          <div class="pathway-edge">
            <div class="edge-line"></div>
            <div class="edge-label">implicated in</div>
          </div>

          <!-- Node 5: Acute Coronary Syndrome -->
          <div class="pathway-node disease">
            <div class="node-icon">üè•</div>
            <div class="node-name">Acute Coronary Syndrome</div>
            <div class="node-meta">D054058 | Disease</div>
          </div>
        </div>
      </div>

      <div class="pathway-explanation">
        <h3>Mechanistic Explanation</h3>
        <ol>
          <li><strong>Tirofiban</strong> is a small‚Äëmolecule inhibitor of platelet glycoprotein IIb/IIIa complexes.</li>
          <li>The drug binds to <strong>Integrin Œ±IIb/Œ≤3</strong> on platelets, blocking fibrinogen binding.</li>
          <li>This directly suppresses <strong>platelet aggregation</strong>, a key step in thrombus formation.</li>
          <li>By reducing thrombus formation in coronary arteries, Tirofiban helps prevent and treat 
              <strong>Acute Coronary Syndrome</strong>.</li>
        </ol>
      </div>
    </section>
  </main>

  <footer>
    <div class="container">
      <p>PrimeKG Pathfinding Algorithm Benchmark Laboratory</p>
      <p>
        <a href="https://github.com/maxxyhc/PrimeKG-Pathfinding-Algorithm-Benchmark-Laboratory" target="_blank">
          View on GitHub
        </a>
      </p>
    </div>
  </footer>
</body>
</html>